The UA Campus Repository is experiencing systematic automated, high-volume traffic (bots). Temporary mitigation measures to address bot traffic have been put in place; however, this has resulted in restrictions on searching WITHIN collections or using sidebar filters WITHIN collections. You can still Browse by Title/Author/Year WITHIN collections. Also, you can still search at the top level of the repository (use the search box at the top of every page) and apply filters from that search level. Export of search results has also been restricted at this time. Please contact us at any time for assistance - email repository@u.library.arizona.edu.

Show simple item record

dc.contributor.authorOkolo, O.
dc.contributor.authorWertheim, B.C.
dc.contributor.authorLarsen, A.
dc.contributor.authorSweeney, N.W.
dc.contributor.authorAhlstrom, J.M.
dc.contributor.authorGowin, K.
dc.date.accessioned2024-08-04T07:10:57Z
dc.date.available2024-08-04T07:10:57Z
dc.date.issued2023-03-02
dc.identifier.citationOkolo, O., Wertheim, B. C., Larsen, A., Sweeney, N. W., Ahlstrom, J. M., & Gowin, K. (2023). Integrative medicine in multiple myeloma and plasma cell disorders. Complementary Therapies in Medicine, 73, 102939.
dc.identifier.issn0965-2299
dc.identifier.pmid36868288
dc.identifier.doi10.1016/j.ctim.2023.102939
dc.identifier.urihttp://hdl.handle.net/10150/673522
dc.description.abstractIntroduction: Integrative Medicine (IM) use and efficacy is poorly defined in those with plasma cell disorders (PCD). A 69-question survey on the subject was hosted on HealthTree.org for 3 months. Method: The survey included questions about complementary practice use, PHQ-2 score, quality of life, and more. Mean outcome values were compared between IM users and non-users. Proportions of supplement users and IM patients were compared between patients currently on myeloma specific treatment and patients not currently on treatment. Results: The top 10 IM modalities reported among 178 participants were aerobic exercise (83 %), nutrition (67 %), natural products (60 %), strength exercise (52 %), support groups (48 %), breathing exercises (44 %), meditation (42 %), yoga (40 %), mindfulness-based stress reduction (38 %), and massage (38 %). The survey showed most patients participated in IM modalities, though they felt uncomfortable discussing them with their oncologist. Participant characteristics were compared between groups (users and non-users) using two-sample t-tests and chi-square tests. Use of vitamin C (3.6 vs. 2.7; p = 0.01), medical marijuana (4.0 vs. 2.9; p = 0.03), support groups (3.4 vs. 2.7; p = 0.04), and massage (3.5 vs. 2.7; p = 0.03) were associated with a higher quality of life scores on MDA-SI MM. There were no other significant associations between supplement use or IM practices and the MDA-SI MM, brief fatigue inventory, or PHQ-2. Conclusion: This study provides a foundation in the understanding of IM use in PCD, but more research is needed to evaluate individual IM interventions and their efficacy. © 2023
dc.language.isoen
dc.publisherChurchill Livingstone
dc.rights© 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectIntegrative medicine
dc.subjectPlasma cell disorders
dc.titleIntegrative medicine in multiple myeloma and plasma cell disorders
dc.typeArticle
dc.typetext
dc.contributor.departmentDepartment of Hematology Oncology, University of Arizona
dc.contributor.departmentUniversity of Arizona Cancer Center, University of Arizona
dc.contributor.departmentDepartment of Medicine, University of Arizona
dc.identifier.journalComplementary Therapies in Medicine
dc.description.noteOpen access article
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.
dc.eprint.versionFinal Published Version
dc.source.journaltitleComplementary Therapies in Medicine
refterms.dateFOA2024-08-04T07:10:57Z


Files in this item

Thumbnail
Name:
1-s2.0-S0965229923000262.pdf
Size:
367.6Kb
Format:
PDF
Description:
Final Published Version

This item appears in the following Collection(s)

Show simple item record

© 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
Except where otherwise noted, this item's license is described as © 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.